Blackstone Life Sciences Fund VI blows past fundraise target
The platform boasts a regulatory approval rate of nearly twice the industry average, division head Nicholas Galakatos tells Buyouts.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- Database
- LP search
- GP search
- Fund search
- Commitments
- Investment Consultant search
- Placement Agent search
- Law Firm search
- Live Fundraising Chart
- Benchmarks
- Family offices
- US Mid-Market Private Equity Data
- Investor Calendar 2026
- Update your database profile
- Database key terms and methodology
- Fund performance methodology
- Quick Search
- Firms & Funds
- LPs
- Research
- Books
- Events
